GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jiudian Pharmaceutical Co Ltd (SZSE:300705) » Definitions » COGS-to-Revenue

Hunan Jiudian Pharmaceutical Co (SZSE:300705) COGS-to-Revenue : 0.26 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Hunan Jiudian Pharmaceutical Co COGS-to-Revenue?

Hunan Jiudian Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥184 Mil. Its Revenue for the three months ended in Mar. 2025 was ¥696 Mil.

Hunan Jiudian Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.26.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Hunan Jiudian Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 was 73.57%.

Hunan Jiudian Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Hunan Jiudian Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jiudian Pharmaceutical Co COGS-to-Revenue Chart

Hunan Jiudian Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.21 0.22 0.23 0.27

Hunan Jiudian Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.26 0.25 0.28 0.26

Hunan Jiudian Pharmaceutical Co COGS-to-Revenue Calculation

Hunan Jiudian Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=784.397 / 2930.677
=0.27

Hunan Jiudian Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=183.926 / 696.028
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Jiudian Pharmaceutical Co  (SZSE:300705) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Hunan Jiudian Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 183.926 / 696.028
=73.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Hunan Jiudian Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hunan Jiudian Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Jiudian Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jiudian Pharmaceutical Co Ltd (SZSE:300705) » Definitions » COGS-to-Revenue
Comparable Companies
SHSE:601089 SZSE:300401 SZSE:002550 SZSE:000650 SHSE:688131 SZSE:300363 SZSE:300702 SZSE:000597 SZSE:002275 SZSE:000989 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No.1 Health Avenue, Hunan Liuyang Bio Pharmaceutical Park, Hunan, Changsha, CHN, 410329
Website
http://www.jiudianph.com
Hunan Jiudian Pharmaceutical Co Ltd is a China-based pharmaceutical company specializing in research and development, manufacturing of pharmaceutical products, solid and liquid oral preparations and herbal extract products. It manufactures dirithromycin, levodropropizine and levocetirizine hydrochloride in China. The group's products include active pharmaceutical ingredients, herbal extracts, intermediaries, excipients and finished products.
Executives
Xiong Ying Executives
Zhu Zhi Hong Director
Duan Bin Supervisors
Liang Sheng Hua Supervisors
Zheng Xia Hui Directors, executives
Duan Li Xin Director
Zhu Zhi Yun Director
Li Min Secretary Dong
Fan Peng Yun Executives

Hunan Jiudian Pharmaceutical Co Headlines

No Headlines